Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. 
This report contains market size and forecasts of Dalfampridine in global, including the following market information:
Global Dalfampridine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dalfampridine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dalfampridine companies in 2021 (%)
The global Dalfampridine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical and Aurobindo Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dalfampridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dalfampridine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dalfampridine Market Segment Percentages, by Type, 2021 (%)
10 mg
Others
Global Dalfampridine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dalfampridine Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Dalfampridine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dalfampridine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dalfampridine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dalfampridine revenues share in global market, 2021 (%)
Key companies Dalfampridine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dalfampridine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma